Cargando…
Transmucosal Buprenorphine in the Treatment of Dyspnea: Case Series and Review of the Literature
Full μ-opioid agonists are commonly employed in advanced disease to relieve dyspnea of various etiologies. Although there are ongoing debates and studies regarding the relative efficacy of different agents, a factor limiting more general use is a concern about side effects, in particular respiratory...
Autores principales: | Blumenfeld-Kouchner, François, Bullis, Lisa, Koch, Kathy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241374/ https://www.ncbi.nlm.nih.gov/pubmed/34223499 http://dx.doi.org/10.1089/pmr.2020.0091 |
Ejemplares similares
-
Pharmacokinetics of intravenous, oral transmucosal, and intranasal buprenorphine in healthy male dogs
por: Enomoto, Hiroko, et al.
Publicado: (2022) -
Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021) -
Notes from the Field: Emergency Visits for Complications of Injecting Transmucosal Buprenorphine Products — United States, 2016–2018
por: Tanwar, Sukarma, et al.
Publicado: (2020) -
An open-label clinical trial of oral transmucosal haloperidol and oral transmucosal olanzapine in the treatment of terminal delirium at home
por: Lyu, Xiao-Juan, et al.
Publicado: (2022) -
Ceftriaxone for the Treatment of Chronic Bacterial Prostatitis: A Case Series and Literature Review
por: Kuiper, Sander G., et al.
Publicado: (2022)